Open AccessCorrection to: Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease: Results from a Phase 1 Randomized Trial
Author(s) -
Wenhui Zhang,
Astrid Scalori,
Franklin Fuh,
Jacqueline McBride,
Gaohong She,
Jarosław Kierkuś,
Bartosz Korczowski,
Regan Li,
Mariam Abouhossein,
Alysha Kadva,
K T Park,
Meina Tang
Publication year - 2022
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izac066
Subject(s) - ulcerative colitis , medicine , pharmacodynamics , randomized controlled trial , crohn's disease , pharmacokinetics , disease , gastroenterology , clinical trial , inflammatory bowel disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom